Uday Kompella
Founder bij OCUGEN, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Uday B.
Kompella is a Director & Chief Scientific Officer, Independent Director, and Director at Ocugen, Inc. and Ocugen OpCo, Inc. respectively, both founded in 2013.
He is also a Professor-Pharmaceutical Sciences at CU Anschutz Medical Campus.
Dr. Kompella holds a doctorate from the University of Southern California, an undergraduate degree from Birla Institute of Technology & Science, and a graduate degree from Jadavpur University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OCUGEN INC
0.27% | 09-06-2023 | 705 090 ( 0.27% ) | 1 M $ | 31-03-2024 |
Actieve functies van Uday Kompella
| Bedrijven | Functie | Begin |
|---|---|---|
| OCUGEN, INC. | Founder | 01-01-2013 |
| Ocugen OpCo, Inc. | Founder | 01-09-2013 |
| CU Anschutz Medical Campus | Corporate Officer/Principal | - |
Eerdere bekende functies van Uday Kompella
| Bedrijven | Functie | Einde |
|---|---|---|
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Founder | - |
Opleiding van Uday Kompella
| University of Southern California | Doctorate Degree |
| Birla Institute of Technology & Science | Undergraduate Degree |
| Jadavpur University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen, Inc. | |
| Ocugen OpCo, Inc. |
